Abstract:Since their inception, genome-wide association studies (GWAS) have identified more than a hundred thousand single nucleotide polymorphism (SNP) loci that are associated with various complex human diseases or traits. The majority of GWAS discoveries are located in non-coding regions of the human genome and have unknown functions. The valley between non-coding GWAS discoveries and downstream affected genes hinders the investigation of complex disease mechanism and the utilization of human genetics for the improvement of clinical care. Meanwhile, advances in high-throughput sequencing technologies reveal important genomic regulatory roles that non-coding regions play in the transcriptional activities of genes. In this review, we focus on data integrative bioinformatics methods that combine GWAS with functional genomics knowledge to identify genetically regulated genes. We categorize and describe two types of data integrative methods. First, we describe fine-mapping methods. Fine-mapping is an exploratory approach that calibrates likely causal variants underneath GWAS signals. Fine-mapping methods connect GWAS signals to potentially causal genes through statistical methods and/or functional annotations. Second, we discuss gene-prioritization methods. These are hypothesis generating approaches that evaluate whether genetic variants regulate genes via certain genetic regulatory mechanisms to influence complex traits, including colocalization, mendelian randomization, and the transcriptome-wide association study (TWAS). TWAS is a gene-based association approach that investigates associations between genetically regulated gene expression and complex diseases or traits. TWAS has gained popularity over the years due to its ability to reduce multiple testing burden in comparison to other variant-based analytic approaches. Multiple types of TWAS methods have been developed with varied methodological designs and biological hypotheses over the past 5 years. We dive into discussions of how TWAS methods differ in many aspects and the challenges that different TWAS methods face. Overall, TWAS is a powerful tool for identifying complex trait-associated genes. With the advent of single-cell sequencing, chromosome conformation capture, gene editing technologies, and multiplexing reporter assays, we are expecting a more comprehensive understanding of genomic regulation and genetically regulated genes underlying complex human diseases and traits in the future.

Decoding polygenic diseases: advances in noncoding variant prioritization and validation

Exploring noncoding variants in genetic diseases: From detection to functional insights

Non-coding genetic variants in human disease

Genetic Study of Complex Diseases in the Post-GWAS Era

A review of post-GWAS prioritization approaches

Genomic annotation of disease-associated variants reveals shared functional contexts

Reaching the End-Game for GWAS: Machine Learning Approaches for the Prioritization of Complex Disease Loci

Technological advancements in functional interpretation of genome‐wide association studies (GWAS) findings: bridging the gap to clinical translation

Scalable approaches for functional analyses of whole-genome sequencing non-coding variants

The landscape of GWAS validation; systematic review identifying 309 validated non-coding variants across 130 human diseases

Diagnostic and Clinical Utility of Whole Genome Sequencing in a Cohort of Undiagnosed Chinese Families with Rare Diseases

From GWAS to Function: Using Functional Genomics to Identify the Mechanisms Underlying Complex Diseases

Integrated analysis of variants and pathways in genome-wide association studies using polygenic models of disease

Genetic studies through the lens of gene networks

Editing GWAS: experimental approaches to dissect and exploit disease-associated genetic variation

Genome-wide association testing beyond SNPs

How chromatin interactions shed light on interpreting non-coding genomic variants: opportunities and future direc-tions

Understanding genetic variants in context

From GWAS to Gene: Transcriptome-Wide Association Studies and Other Methods to Functionally Understand GWAS Discoveries

Mapping structural variants to rare disease genes using long-read whole genome sequencing and trait-relevant polygenic scores

Translation of genome-wide association study: from genomic signals to biological insights